Board / shareholder meeting outcomeNotableFiled on BSE ·

Titan Biotech Limited holds 34th Annual General Meeting via video conferencing on Sept 29, 2026

Titan Biotech · Chemicals & Petrochemicals

Arthneeti Research DeskPublished 1 min read

Key highlights

  • Meeting held through VC/OAVM as per Companies Act and SEBI regulations, commenced at 3:00 PM IST and concluded at 4:09 PM IST
  • Ordinary businesses included adoption of audited financial statements for FY ended March 31, 2026, dividend declaration, and re-appointment of directors
  • Special businesses covered increase in authorized share capital, issuance of bonus shares, loans authorization, cost auditor remuneration, mortgage of company property, and re-appointment of independent director

Why it's rated notable: The AGM filing lists proposals including a bonus issue and a dividend declaration but does not report the voting results, so the business outcome is not yet confirmed.

Original filing

Shareholder Meeting / Postal Ballot-Outcome of AGM

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Other board / shareholder meeting outcome filings this fortnight

All board / shareholder meeting outcome filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.